miRNA-483–5p Targets HDCA4 to Regulate Renal Tubular Damage
                    in Diabetic Nephropathy

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

Facebook X Linkedin Weibo

PDF herunterladen

Horm Metab Res 2021; 53(08): e4
DOI: 10.1055/a-1534-3166

Erratum

Lu Liu‡

¹Department of Endocrinology, Seventh People’s Hospital of Shanghai University of TCM, 200137, Shanghai, China

,

Huanzhen Chen‡

²Department of Endocrinology, Putuo People’s Hospital, Tongji University, Shanghai, 200060, China

,

Jie Yun

³Department of Nephrology, Heilongjiang University of Chinese Medicine, Heilongjiang, China

,

Liqun Song

³Department of Nephrology, Heilongjiang University of Chinese Medicine, Heilongjiang, China

,

Xiaopeng Ma

³Department of Nephrology, Heilongjiang University of Chinese Medicine, Heilongjiang, China

,

Shan Luo

³Department of Nephrology, Heilongjiang University of Chinese Medicine, Heilongjiang, China

,

Yexu Song

⁴Department of Science and Technology, Heilongjiang University of Chinese Medicine, Heilongjiang, China

miRNA-483-5p targets HDCA4 to regulate renal tubular damage in diabetic nephropathy

Liu L, Chen H, Yun J, et al. Horm Metab Res 2021; 53,

In the above-mentioned article, the name of an author was misspelled. The correct Spelling is: Huanzhen Chen

Artikel online veröffentlicht:
16. Juli 2021

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany